Didier Cataldo,Brigitte Evrard,Gilles Dufour,Pascal de Tullio,Paul Maes
申请号：
US14672831
公开号：
US20160051568A1
申请日:
2015.03.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to novel and useful pharmaceutical compositions formulated with a cyclodextrin compound and a budesonide derivative for the treatment and/or prevention of pulmonary inflammatory disease. The present invention also relates to a novel and useful analytical technique for the detection and the quantification of HP-β-CD in solution. More specifically, the present invention relates to the use of a validated 1H NMR analysis for the detection and quantification of cyclodextrins directly in pharmaceutical formulations without any extraction or separation steps for liquid formulations.
